Home › Funds › VALLEY FORGE INVESTMENT CONSULTANTS INC ADV › NGEN

VALLEY FORGE INVESTMENT CONSULTANTS INC ADV position in NGEN

NERVGEN PHARMA CORP · Health Care

VALLEY FORGE INVESTMENT CONSULTANTS INC ADV reported holding 834,156 shares of NGEN (NERVGEN PHARMA CORP) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.39% of its reported portfolio and ranking #25 among its reported holdings. VALLEY FORGE INVESTMENT CONSULTANTS INC ADV has disclosed NGEN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)834.16K sh
Reported value held$1.59M
Portfolio Weight0.39%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VALLEY FORGE INVESTMENT CONSULTANTS INC ADV's NGEN position evolved

VALLEY FORGE INVESTMENT CONSULTANTS INC ADV first disclosed a stake in NGEN in Q1 2026 at 77,698 shares (US$293K). The position peaked in Q3 2026 at 834,156 shares, worth US$1.6M. Across 3 filings, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 834,156 shares valued at US$1.6M — an increase of 824,156 shares quarter over quarter.. Notable position changes include a 87% trim in Q2 2026 (shares fell 7% over the following quarter), a 8242% increase in Q3 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 77.70K $292.92K New
Q2 2026 10.00K $20.60K Reduce
Q3 2026 834.16K $1.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NGEN and 13F data

NGEN (NERVGEN PHARMA CORP) is a Health Care company. 73 other funds we track also report a position in NGEN — the largest reported positions include Empery Asset Management, LP (US$8.2M), DAFNA Capital Management LLC (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NGEN

All NGEN fund holders →

FAQ

How long has VALLEY FORGE INVESTMENT CONSULTANTS INC ADV held NGEN?

VALLEY FORGE INVESTMENT CONSULTANTS INC ADV has disclosed NGEN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is VALLEY FORGE INVESTMENT CONSULTANTS INC ADV's current position in NGEN?

As of Q3 2026, VALLEY FORGE INVESTMENT CONSULTANTS INC ADV holds 834.16K shares of NGEN (NERVGEN PHARMA CORP), valued at $1.59M, representing 0.39% of its reported portfolio and ranking #25.

Has VALLEY FORGE INVESTMENT CONSULTANTS INC ADV been buying or selling NGEN?

In the latest 13F filing (Q3 2026), VALLEY FORGE INVESTMENT CONSULTANTS INC ADV increased its position in NGEN. The position peaked in Q3 2026 at 834.16K shares.

Which other funds hold NGEN?

Other major institutional holders of NGEN include Empery Asset Management, LP, DAFNA Capital Management LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.